Eosinophilic granulomatosis with polyangiitis

Alexandra M. Nanzer, Michael E. Wechsler

Source: Eur Respir Monogr 2022; 95: 177-192

Congress or journal article abstractFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Alexandra M. Nanzer, Michael E. Wechsler. Eosinophilic granulomatosis with polyangiitis. Eur Respir Monogr 2022; 95: 177-192

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Biologics for eosinophilic granulomatosis with polyangiitis
Source: Short video statement 2020
Year: 2020

Microscopic polyangiitis and granulomatosis with polyangiitis
Source: Eur Respir Monogr 2019; 86: 153-172
Year: 2019


Frequency of eosinophilic granulomatosis with polyangiitis in Europe by meta-analysis
Source: Virtual Congress 2020 – Prevalence and incidence of chronic lung diseases
Year: 2020


Eosinophilic granulomatosis with polyangiitis (formerly Churg–Strauss syndrome): where are we now?
Source: Eur Respir J 2015; 46: 1255-1258
Year: 2015


Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis
Source: ERJ Open Res, 6 (4) 00451-2020; 10.1183/23120541.00451-2020
Year: 2020



Granulomatosis with polyangiitis (Wegener&s)
Source: Eur Respir Mon 2011; 54: 1-14
Year: 2011


Pulmonary hypertension as the first manifestation in a patient with granulomatosis with polyangiitis
Source: International Congress 2019 – Pulmonary vascular diseases?
Year: 2019

Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg–Strauss)
Source: Eur Respir J 2016; 48: 1429-1441
Year: 2016



New biomarkers for early diagnosis of eosinophilic granulomatosis with polyangiitis (EGPA)
Source: International Congress 2017 – Techniques to treat asthma
Year: 2017


Lung-limited Granulomatosis with polyangiitis (GPA) managed without immunosuppression
Source: International Congress 2018 – CC5 Pulmonary vasculitis: the great chameleon
Year: 2018


Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis
Source: ERJ Open Res, 6 (1) 00311-2019; 10.1183/23120541.00311-2019
Year: 2020



Coexistent granulomatosis with polyangiitis (Wegener‘s) and Crohn disease: A clinicopathologic description of cases
Source: Annual Congress 2012 - Pulmonary manifestations of systemic diseases
Year: 2012

Relapsing necrotising sarcoid granulomatosis in a young patient
Source: Eur Respir J 2007; 29: 816
Year: 2007


Fatal haemoptysis in a case of lymphomatoid granulomatosis treated with rituximab
Source: Eur Respir J 2006; 27: 644-646
Year: 2006



Wegener's granulomatosis: our experience
Source: Eur Respir J 2001; 18: Suppl. 33, 511s
Year: 2001

Twelve month outcomes with Reslizumab treatment of Eosinophilic Granulomatosis with Polyangiitis
Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies
Year: 2019

Radiological findings in patients with Wegener granulomatosis
Source: Eur Respir J 2003; 22: Suppl. 45, 593s
Year: 2003

Secondary organizing pneumonia (BOOP)-associated with granulomatosis with polyangiitis [Wegener granulomatosis (WG)]: A clinicoradiological study of 19 cases
Source: International Congress 2014 – ILDs 6
Year: 2014